InvOpps GP IV, L.L.C. is Director & 10% Owner at Oyster Point Pharma, Inc. (OYST). They have made 1 open-market trade across 1 company since 2019, most recently 2023-01-03.
CIK 0001792570
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12.0M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OYST | 1,230,050 | $13.7M |
Shares reported on the most recent Form 4, priced at the 2019-11-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OYST | BUY | 2019-11-04 | 2019-11-06 | $16.00 | $12.0M | -9.0% | +3.9% | +96.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.